Here are several updates in medical imaging contrast media agents.
Contrast Media
-
-
July 18, 2017 — Guerbet recently announced that it will phase out sales throughout the world of two products: Hexabrix (meglumine and sodium ioxaglate) and Optimark (gadoversetamide).
-
A U.S. Food and Drug Administration (FDA) review of the safety ramifications of gadolinium-based contrast agents for magnetic resonance imaging (MRI) has not identified adverse health affects from gadolinium retained in the brain. The FDA released a drug safety communication regarding all...
-
The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency recently released new recommendations on procedures employing gadolinium-based contrast agents, in which the committee recommended suspension of marketing authorization for four agents.
-
The most prevalent method for obtaining images of clogged coronary vessels is coronary angiography. For some patients, however, the contrast agents used in this process can cause health problems. A team at the Technical University of Munich (TUM) has now demonstrated that the required quantity...
News | Contrast Media | August 15, 2017
August 15, 2017 — The International Society for Magnetic Resonance in Medicine (ISMRM) has provided new guidance in...
Feature | Contrast Media | July 28, 2017 | By Dave Fornell
Here are several updates in medical imaging ...
News | Contrast Media | July 18, 2017
July 18, 2017 — Guerbet recently announced that it will phase out sales throughout the world of two products:...
News | Contrast Media | July 17, 2017
July 17, 2017 — The American College of Radiology (ACR) recently revised its authoritative guide for the safe and...
Technology | CT Angiography (CTA) | June 16, 2017
June 16, 2017 — The U.S. Food and Drug Administration (FDA) has expanded the indication for GE Healthcare’s ...
Feature | Magnetic Resonance Imaging (MRI) | May 25, 2017
May 25, 2017 — A U.S. Food and Drug Administration (FDA) review of the safety ramifications of gadolinium-based...
The ZD2-Gd probe, represented by the orange ball and green arrow, binds to the EDB-FN in the prostate cancer cells with high metastatic potential. This results in a strong MRI signal (upper right). Prostate cancer cells with low metastatic potential have no EDB-FN and so there is no MRI signal (lower right). Credit: Han, et al., Bioconjug Chem-Apr-2017
News | Prostate Cancer | May 24, 2017
May 24, 2017 — A research team funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) has...
News | Magnetic Resonance Imaging (MRI) | May 03, 2017
May 3, 2017 — Scientists from the National University of Singapore (NUS) have developed a novel nanodiamond-based...
Sponsored Content | Case Study | Contrast Media Injectors | April 13, 2017
Improving Efficiency and Reducing Waste
The volume of computed tomography (CT) imaging exams continues to...
News | Contrast Media | March 13, 2017
March 13, 2017 — The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency recently...
(a) Photograph of the sample in waterbath. (b) Empty image of full MuCLS beam. (c) Quasi-mono-energetic angiography image of a porcine heart acquired at the MuCLS, with iodine-based contrast agent injected into the left coronary artery. Visible are the left anterior descending artery (LAD) and the left circumflex artery (LCX). Image courtesy of the authors.
News | Angiography | March 10, 2017
March 10, 2017 — The most prevalent method for obtaining images of clogged coronary vessels is coronary...
Feature | Contrast Media Injectors | March 02, 2017 | By Jeff Zagoudis
With medical imaging use on the rise, contrast media...
Technology | Contrast Media | February 02, 2017
February 2, 2017 — Lantheus Medical Imaging Inc. announced U.S. Food and Drug Administration (FDA) approval of a...
A new study in Annals of Emergency Medicine finds no association between intravenous contrast media used in computed tomography (CT) and kidney damage. Roughly 80 million doses of IV contrast media are given every year. Credit: American College of Emergency Physicians
News | Contrast Media | January 30, 2017
January 30, 2017 — Intravenous contrast media (typically iohexol or iodixanol) used in...
Videos | Magnetic Resonance Imaging (MRI) | December 12, 2016
Emanuel Kanal, M.D., director of MRI services and professor of radiology and neuroradiology at the University of...
News | Contrast Media | December 09, 2016
At the 2016 Annual Meeting of the Radiological Society of North America (RSNA...
Technology | Contrast Media Injectors | December 05, 2016
December 5, 2016 — Bracco Diagnostics Inc. announced that CT Exprès — the first and only multi-dose, multi-patient,...
Technology | Contrast Media | October 04, 2016
October 4, 2016 — GE Healthcare announced that the U.S. Food and Drug Administration (FDA) has approved a label...
News | Ultrasound Imaging | September 12, 2016
September 12, 2016 — Tiny microbubbles are being used to more effectively...
News | Ultrasound Imaging | September 07, 2016
September 7, 2016 — Toshiba America Medical Systems Inc. announced that its Aplio 500 Platinum...
